Features

The Features section includes articles on topics, events, people, and initiatives of interest to the oncology community.

Dec 22, 2016
Dr. Simone M. Goldinger shares her experiences conducting research at melanoma centers all over the world.
Dec 22, 2016
In December 2016, Jonathan S. Berek, MD, MMS, FASCO, concluded his second term as ASCO Connection editor in chief, a position he had held since 2006. Dr. Berek is the Laurie Kraus Lacob Professor and director of the Stanford Women’s Cancer Center at the Stanford Cancer Institute, where he specializes in gynecologic oncology, and chair of...
Dec 22, 2016
The new law, called the Medicare Quality Payment Program, not only promises to deliver a more consistent and reliable system of payment compared to the previous SGR, but also heralds a fundamental shift in CMS’s conception of reimbursement incentives.
Oct 25, 2016
More than 650 attendees gathered in San Francisco on September 9 and 10 for the 2016 Palliative Care in Oncology Symposium, focusing on the theme of “Patient-Centered Care Across the Cancer Continuum.”
Oct 24, 2016
ASCO opened participant enrollment for the Targeted Agent and Profiling Utilization Registry (TAPUR) Study in March 2016, marking a major milestone in the conduct of the Society’s first-ever clinical trial.
Oct 21, 2016
There has been no better time than the present for women in the field of oncology, yet even with all of the hard-fought advances women in medicine have made over the last 40 years, challenges stemming from internalized biases at the personal and institutional level persist.
Oct 20, 2016
Dr. Maha Hussain is co-director of the Lurie Cancer Center Genitourinary Oncology Program, ASCO Board of Directors member, and ASCO Clinical Practice Guidelines Committee member.
Oct 13, 2016
Dr. Tom John reviews recent studies exploring immunotherapy as a treatment for mesothelioma, and considers the role of the Cancer Moonshot Initiative for facilitating new research in rare diseases.
Aug 24, 2016
Dr. Verweij is Dean of the Faculty of Medicine at Erasmus University, the Netherlands; Associate Editor for the Journal of Clinical Oncology; and ASCO Board of Directors Member
Aug 24, 2016
The innovative, holistic research strives to answer the question, are there biologic or quality-of-life markers that differentiate long-term survivors of ovarian cancer?

Pages